1. Market Research
  2. > Pathology
35 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Pet Cancer Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 4250
  • July 2020
  • 113 pages

The most common site for lymphoma is the lymph nodes.

  • Cancer
  • Lymphoma
  • Therapy
  • Boehringer Ingelheim GmbH
  • Elanco

Veterinary Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 4250
  • July 2020
  • 124 pages

Some cancers, such as lymphoma, are more common in cats than in dogs.

  • Diagnostics
  • Lymphoma
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Randox Laboratories Ltd.

Veterinary Diagnostic Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • September 2019
  • 96 pages

Some cancers, such as lymphoma, are more common in cats than in dogs.

  • Diagnostic Imaging
  • Lymphoma
  • Carestream Health, Inc.
  • Esaote S.P.A.
  • FUJIFILM Holdings Corporation

Stem Cell Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 4250
  • May 2020
  • 120 pages

According to the Leukemia & Lymphoma Society (LLS) estimates, around ##, ## people in the United States were diagnosed with leukemia, lymphoma, or myeloma in 2019.

  • Cell Therapy
  • Lymphoma
  • Therapy
  • Becton Property Group
  • Becton, Dickinson and Company, Ltd

Alpha Emitter Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • December 2019
  • 101 pages

A##Th immunoconjugate has been investigated against lymphoma.

  • Cancer
  • Lymphoma
  • United States
  • Actinium Pharmaceuticals, Inc.
  • Bayer AG

Kidney Cancer Therapeutics & Diagnostics Market- Growth, Trends, and Forecasts (2020 – 2025)

  • $ 4250
  • July 2020
  • 135 pages

ADCETRIS is approved for some CD##-expressing lymphomas, while PADCEV is approved for certain metastatic urothelial cancers.

  • Cancer
  • Diagnostics
  • Lymphoma
  • Renal Cancer
  • Therapy

Precision Medicine Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • December 2019
  • 112 pages

PREDICTIVE BIOMARKERS FOR PRECISION MEDICINE IN LUNG CANCER THERAPY ARE DONE WITH DRUGS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ANAPLASTIC LYMPHOMA KINASE (ALK), C-ROS ONCOGENE-## RECEPTOR TYROSINE KINASE (ROS##), AND IMMUNE CHECKPOINTS.

  • Healthcare
  • Lymphoma
  • Biocrates Life Sciences AG
  • F. Hoffmann-La Roche Ltd.
  • NanoString Technologies, Inc.

Biopharmaceuticals Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 5000
  • August 2019
  • 178 pages

According to the Leukemia and Lymphoma Society (LLS), United States, an estimated combined total of ##, ## people in the United States are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2019.

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • United States
  • Market Size

Clean Label Ingredients Market - Growth, Trends and Forecast (2019 - 2024)

  • $ 4250
  • December 2019
  • 146 pages

Aspartame, an artificial sweetener, is associated with diseases, like depression, headaches, and cancer, which include lymphoma and leukemia.

  • Food Manufacturing
  • Archer Daniels Midland Company
  • Cargill Inc.
  • DuPont
  • Frutarom Industries Ltd.

Asia Pacific Apheresis Market - Growth, Trends, and Forecast (2019-2024)

  • $ 3750
  • August 2019
  • 70 pages

According to the Asia-Pacific Report by Janssen Oncology, in 2017, there were ##, ## combined new cases of leukemia, lymphoma, and myeloma in Australia.

  • Blood Supply
  • Lymphoma
  • APAC
  • Forecast
  • B. Braun Melsungen AG

Gene Therapy Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • September 2019
  • 113 pages

In March 2018, Novartis received the approval to sell its Kymriah CAR-T gene therapy in Japan for USD ##, ##, to treat acute lymphoblastic leukemia (ALL) and adult patients with diffuse large B-cell lymphoma (DLBCL).

  • Gene Therapy
  • Lymphoma
  • United States
  • Amgen Inc.
  • Biogen Idec Inc.

South Africa In-Vitro Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 3250
  • November 2019
  • 69 pages

Some of the most common blood disorders in the country include anaemia, sickle cell anaemia, lymphoma, leukaemia, idiopathic thrombocytopenic purpura, primary thrombocythemia, sepsis, and hemophilia, among others.

  • In Vitro Diagnostics
  • Lymphoma
  • South Africa
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

Veterinary Molecular Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • April 2019
  • 108 pages

For example, Purdue University' s College of Veterinary Medicine( Indiana, United States) is conducting clinical trials, and is thus, leading the way in comparative oncology research by discovering new ways to identify and cure lymphomas in canines, which involve using molecular diagnos

  • Biotech Diagnostics
  • Diagnostics
  • Lymphoma
  • Molecular Diagnostics
  • World

Companion Animal Healthcare Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • February 2020
  • 125 pages

The company also signed an agreement with VetDC, for Tanovea-CA##, which is the first US FDA-conditionallyapproved canine lymphoma treatment.

  • Healthcare
  • Lymphoma
  • Boehringer Ingelheim GmbH
  • Elanco
  • Heska Corporation

Companion Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • April 2020
  • 113 pages

In January 2018, NanoString Technologies and Riken Genesis of Kawasaki entered a collaboration to register, obtain reimbursement, and commercialize companion diagnostic assays in Japan, including NanoString' s Lymphoma Subtyping Test, which will be marketed as the nCounter Dx LymphMarkT

  • Diagnostics
  • Lymphoma
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation

VITAMIN A MARKET - GROWTH, TRENDS AND FORECAST(2019-2024)

  • $ 4250
  • April 2019
  • 105 pages

GLOBAL VITAMIN A MARKET Analysis of Growth, Trends, and Forecast (2019 - 2024) Report TABLE OF CONTENTS ##.

  • Lymphoma
  • Vitamin
  • BASF SE
  • Bluestar Adisseo Co Ltd
  • Koninklijke DSM N.V.

Cancer Vaccines Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • March 2020
  • 111 pages

THESE ARE USED FOR TREATING LARGE B-CELL LYMPHOMA\ (DLBCL), PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL), AND ACUTE LYMPHOBLASTIC LEUKEMIA.

  • Cancer
  • Cancer Immunotherapy
  • Lymphoma
  • Therapy
  • F. Hoffmann-La Roche Ltd.

Cancer Biomarkers Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • March 2020
  • 120 pages

The biomarkers for other cancers, such as lymphoma and melanoma, are CD## Antigen, FIP##L##-PDGRF Alpha, PML/ RAR Alpha, BRAF, etc.

  • Biomarker
  • Cancer
  • Lymphoma
  • United States
  • F. Hoffmann-La Roche Ltd.

Nuclear Medicine Radioisotopes Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • March 2020
  • 109 pages

This technique can be used for imaging of lung cancer, lymphoma, head and neck tumors, breast cancer, esophageal cancer, colorectal cancer, and urinary tract tumors.

  • Diagnostic Imaging
  • Lymphoma
  • Medical Device
  • Nuclear Imaging Equipment
  • Cardinal Health, Inc.

Breast Implant Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • December 2019
  • 105 pages

LYMPHOMA IS THE CANCER OF THE LYMPHATIC SYSTEM.

  • Lymphoma
  • Medical Device
  • Prosthesis
  • United States
  • Allergan plc
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on